Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 10/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | NAMPT | P43490 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5026434 | 0.85 | BACE1 (0.41) | BACE1CYP1A2CYP3A4CYP2C9CYP2C19 | |
| Trifluoroacetic Acid SCHEMBL5001971 | 0.84 | BACE1 (0.68) | BACE1LMNA | |
| SCHEMBL5138879 | 0.82 | BACE1 (0.46) | BACE1LMNAHDAC6CYP1A2CYP3A4 | |
| SCHEMBL5025791 | 0.81 | BACE1 (0.47) | BACE1LMNAHDAC6CYP1A2CYP3A4 | |
| SCHEMBL5028464 | 0.80 | LMNA (0.40) | BACE1LMNAALDH1A1HDAC6CYP1A2 | |
| SCHEMBL8241111 | 0.79 | BACE1 (0.62) | BACE1 | |
| Trifluoroacetic Acid SCHEMBL5005126 | 0.74 | BACE1 (0.57) | BACE1LMNA | |
| SCHEMBL5030127 | 0.74 | BACE1 (0.36) | BACE1LMNACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL5025594 | 0.73 | LMNA (0.40) | BACE1LMNAALDH1A1HDAC6 | |
| SCHEMBL4997237 | 0.71 | BACE1 (0.51) | BACE1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1957462-A2 | NOVEL 2-AMINO-HETEROCYCLES UDEFUL IN THE TREATMENT OF ABETA-RELATED PATHOLOGIES | Astra Zeneca AB (SE) | 2008-08-20 | — | — | EP | claimed |
| WO-2007058583-A2 | NOVEL 2-AMINO-HETEROCYCLES USEFUL IN THE TREATMENT OF ABETA-RELATED PATHOLOGIES | ASTRAZENECA AB (SE) | 2007-05-24 | — | — | WO | claimed |